MRX : NYSE
Industry: Pharmaceuticals

COMPANY PROFILE

Company Details

Medicis Pharmaceutical Corporation. The Group's principal activities are developing and marketing products for the treatment of dermatological, aesthetic and podiatric conditions. The Group offers various products addressing various conditions or aesthetic improvements, including facial wrinkles, acne, fungal infections, rosacea, hyperpigmentation, ... More
Shares Outstanding 59.5M
Institutional Ownership 93.32%
Market Cap 1.4B
Last Stock Split 1/26/04 2:1
Jonah Shacknai Corporate Officer Address: 7720 North Dobson Road,Scottsdale,ARIZONA 85256 www.medicis.com

Investment Ratings

MRX Highlights

First Call expects 0.59 EPS for next quarter.
The current Price Target for MRX is $23.50.


COMPANY PERFORMANCE

Pricing Momentum
23.81
Last
----
Today’s Change
--
Today’s Open
--
Day High
--
Day Low
--
Volume 
Quotes delayed by at least 20 minutes

Growth Rates

Earnings per Share

Revenue

Dividend


MRX  IndustryMouse over chart for more details

Loading...
Loading...